Transcept Pharmaceuticals Revenue Quarterly YoY Growth:
-99.27% for Dec. 31, 2012Transcept Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -99.27% |
| Sept. 30, 2012 | 1570% |
| June 30, 2012 | -84.22% |
| March 31, 2012 | -100.0% |
| Dec. 31, 2011 | 310.2% |
| Sept. 30, 2011 | -80.00% |
| June 30, 2011 | 0.00% |
| March 31, 2011 | 0.00% |
| Dec. 31, 2010 | 0.00% |
| Sept. 30, 2010 | 50.02% |
| June 30, 2010 | |
| March 31, 2010 | |
| Dec. 31, 2009 | |
| Sept. 30, 2009 | 2140% |
| June 30, 2009 | -100.0% |
| March 31, 2009 | -100.0% |
| Dec. 31, 2008 | |
| Sept. 30, 2008 | -98.91% |
| June 30, 2008 | 39414% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
TSPT Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Cleveland BioLabs | 11.08% |
| Achillion Pharmaceuticals | -100.0% |
| Repros Therapeutics | 100.0% |
TSPT Revenue Quarterly YoY Growth Rankings
| Overall |
36th percentile 4786 of 7593 |
| Sector |
22nd percentile 501 of 650 in Healthcare |
| Industry |
38th percentile 146 of 237 in Biotechnology |
TSPT Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -100.0% | Mar 2009 |
| Maximum | 39414% | Jun 2008 |
| Average | 2855% |
